United KingdomHealthcare and life sciences2023 – ongoingLondon North West University Healthcare NHS Trust
Sanius AI-supported remote monitoring for sickle cell disease
London North West enrolled more than 50 people in AI-supported sickle-cell monitoring
Problem
The trust wanted a clearer understanding of how sickle cell disease affected patients between clinical encounters. Day-to-day monitoring could provide data for research into pain and complications.
Approach
Participants used Sanius Health's remote-monitoring platform, combining a smartwatch with a smartphone app. The trust described AI-supported collection and analysis of patient data. Predictive medicine was an intended research use.
Results
Takeaway
Participation established that remote data collection was underway. The trust did not report prediction accuracy or improved clinical outcomes.
Categories
- Industry
- Healthcare and life sciences
- Business function
- Production and qualityIT and R&D
- Innovation type
- Process innovation
- AI technology
- Predictive analytics and ML
- Adoption
- Vendor solution
- Goal
- Quality and risk
- Evidence
- Company's own claim
Sources
Source summaries
The trust reported more than 50 participants using Sanius Health's monitoring platform. It described research ambitions without reporting clinical-effectiveness results.
Full details are in the original sources.